See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2019_ALEXION_PHARMACEUTICALS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000899866')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000899866, ALEXION PHARMACEUTICALS INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 3,385,000,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 8,678,700,000 |
2 | PropertyPlantAndEquipmentNet | 1,471,500,000 |
3 | remainder_Assets | 396,700,000 |
4 | LiabilitiesCurrent | 1,174,000,000 |
5 | LiabilitiesNoncurrent | 2,657,300,000 |
6 | remainder_Liabilities | 935,300,000 |
7 | CostOfGoodsAndServicesSold | 374,300,000 |
8 | SellingGeneralAndAdministrativeExpense | 1,111,800,000 |
9 | ResearchAndDevelopmentExpense | 1,913,400,000 |
10 | remainder_Expenses | 724,900,000 |
11 | remainder_Revenues | 4,131,200,000 |
12 | remainder_NetIncome | 70,800,000 |
13 | remainder_ComprehensiveNetIncome | 24,700,000 |
yvar | yval | |
---|---|---|
0 | Assets | 13,931,900,000 |
1 | Liabilities | 4,766,600,000 |
2 | Expenses | 4,124,400,000 |
3 | Revenues | 4,131,200,000 |
4 | StockholdersEquity | 9,165,300,000 |
5 | NetIncome | 77,600,000 |
6 | ComprehensiveNetIncome | 89,950,000 |
7 | BaseVar | 13,524,800,000 |
8 | EconomicCapitalRatio | 1.70 |